Essential Medicines in a High Income Country: Essential to Whom?
about
Medicine shortages in Fiji: A qualitative exploration of stakeholders' views.Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures.Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications
P2860
Essential Medicines in a High Income Country: Essential to Whom?
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Essential Medicines in a High Income Country: Essential to Whom?
@ast
Essential Medicines in a High Income Country: Essential to Whom?
@en
Essential Medicines in a High Income Country: Essential to Whom?
@nl
type
label
Essential Medicines in a High Income Country: Essential to Whom?
@ast
Essential Medicines in a High Income Country: Essential to Whom?
@en
Essential Medicines in a High Income Country: Essential to Whom?
@nl
prefLabel
Essential Medicines in a High Income Country: Essential to Whom?
@ast
Essential Medicines in a High Income Country: Essential to Whom?
@en
Essential Medicines in a High Income Country: Essential to Whom?
@nl
P2093
P2860
P1433
P1476
Essential Medicines in a High Income Country: Essential to Whom?
@en
P2093
Rebekah J Moles
World Hospital Pharmacy Research Consortium (WHoPReC)
P2860
P304
P356
10.1371/JOURNAL.PONE.0143654
P407
P577
2015-12-09T00:00:00Z